The online community for biotechnology industry of Switzerland.

SuisseBio has seen steady growth since 2004 and is expected to continue to expand. The Swiss biopharmaceutical market’s strength lies in the ability to carry products to the final stage of development. Switzerland ranks second in the number of pipelines in all phases according to Ernst & Young. Although Switzerland is a smaller country, its success has placed this Hotbed in the company of the world’s most successful biotechnology markets.

Join the World Discussion Forum

Click here to Search Jobs

Hotbed News
3 Biotechs With Make-or-Break Trial Results, FDA Meetings Coming Soon Monday, September 25, 2017
Novartis AG (NVS)' 475,000 CAR-T Drug Price Comes Under Fire Friday, September 22, 2017
Axovant (AXON)'s Much-Hyped Alzheimer's Drug Flunks Phase III Test Tuesday, September 26, 2017
Amgen (AMGN), Allergan (AGN) Make History With First Cancer Biosimilar OK—Will Take on Genentech (RHHBY)'s $6 Billion Best-Seller Monday, September 25, 2017
Former GlaxoSmithKline (GSK) CEO and R&D Boss Secure New Gigs at Biotech VC Firms Monday, September 25, 2017
Nestle's Galderma Laboratories to Slash Up to 450 Jobs at R&D Center Friday, September 22, 2017
Roche (RHHBY) Slammed With Partial Holds for Two Combo Cancer Trials Thursday, September 21, 2017
Incoming Novartis AG (NVS) CEO Lays Out 'Productivity Revolution' Quest in First Interview Tuesday, September 26, 2017
Startup Whiz Kid Vivek Ramaswamy Does it Again, Launches Bay Area Firm to Revolutionize Clinical Trials Friday, September 22, 2017
Is This The Best Oncology Play In The Market? Tuesday, September 19, 2017